Septal Nuclei Neurons
Introduction <table class="infobox infobox-cell"> <tr> <th class="infobox-header" colspan="2">Septal Nuclei Neurons</th> </tr> <tr> <td class="label">Cell Type Name </td> <td>Septal Nuclei [Neurons](/entities/neurons)</td> </tr> <tr> <td class="label">Allen Atlas ID </td> <td>Not applicable (subcortical structure)</td> </tr> <tr> <td class="label">Lineage </td> <td>Mixed: GABAergic and cholinergic neurons</td> </tr> <tr> <td class="label">Brain Regions </td> <td>Medial septal nucleus, Lateral septal nucleus</td> </tr> <tr> <td class="label">Neurotransmitters </td> <td>GABA, [Acetylcholine](/entities/acetylcholine)</td> </tr> <tr> <td class="label">Marker Genes </td> <td>CHAT, GAD1, PVRL1, NTN1</td> </tr> <tr> <td class="label">Taxonomy</td> <td>ID</td> </tr> <tr> <td class="label">Cell Ontology (CL)</td> <td>[CL:0002610](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002610)</td> </tr> <tr> <td class="label">Subtype</td> <td>Markers</td> </tr> <tr> <td class="label">Cholinergic MSNs</td> <td>CHAT, SLC18A3 (VAChT), AChE</td> </tr> <tr> <td class="label">GABAergic LS interneurons</td> <td>GAD1, GAD2, SST</td> </tr> <tr> <td class="label">Septohippocampal projection</td> <td>NTRK2 (TrkB), CNTFR</td> </tr> <tr> <td class="label">Local circuit neurons</td> <td>PVALB, CALB1</td> </tr> </table>
...
Septal Nuclei Neurons
Introduction <table class="infobox infobox-cell"> <tr> <th class="infobox-header" colspan="2">Septal Nuclei Neurons</th> </tr> <tr> <td class="label">Cell Type Name </td> <td>Septal Nuclei [Neurons](/entities/neurons)</td> </tr> <tr> <td class="label">Allen Atlas ID </td> <td>Not applicable (subcortical structure)</td> </tr> <tr> <td class="label">Lineage </td> <td>Mixed: GABAergic and cholinergic neurons</td> </tr> <tr> <td class="label">Brain Regions </td> <td>Medial septal nucleus, Lateral septal nucleus</td> </tr> <tr> <td class="label">Neurotransmitters </td> <td>GABA, [Acetylcholine](/entities/acetylcholine)</td> </tr> <tr> <td class="label">Marker Genes </td> <td>CHAT, GAD1, PVRL1, NTN1</td> </tr> <tr> <td class="label">Taxonomy</td> <td>ID</td> </tr> <tr> <td class="label">Cell Ontology (CL)</td> <td>[CL:0002610](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002610)</td> </tr> <tr> <td class="label">Subtype</td> <td>Markers</td> </tr> <tr> <td class="label">Cholinergic MSNs</td> <td>CHAT, SLC18A3 (VAChT), AChE</td> </tr> <tr> <td class="label">GABAergic LS interneurons</td> <td>GAD1, GAD2, SST</td> </tr> <tr> <td class="label">Septohippocampal projection</td> <td>NTRK2 (TrkB), CNTFR</td> </tr> <tr> <td class="label">Local circuit neurons</td> <td>PVALB, CALB1</td> </tr> </table>
Septal Nuclei Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The septal nuclei are a collection of neuronal clusters located in the medial aspect of the forebrain, forming part of the septal region. They play crucial roles in memory consolidation, emotional regulation, and hippocampal-cortical communication. [@graybiel1978]
Overview <!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
Morphology & Electrophysiology
Morphology : raphe nuclei neuron (source: Cell Ontology)
Morphology can be inferred from Cell Ontology classification
External Database Links
[Cell Ontology (CL:0002610)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002610)
[OBO Foundry (CL:0002610)](http://purl.obolibrary.org/obo/CL_0002610)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
Morphology and Markers Septal nuclei contain two major neuronal populations:
Cholinergic neurons (medial septal nucleus): Large pyramidal-shaped neurons expressing choline acetyltransferase (ChAT), essential for hippocampal theta rhythm generation and memory consolidation.
GABAergic neurons (lateral septal nucleus): Smaller interneurons and projection neurons expressing GAD1/GAD67, involved in emotional processing and hippocampal inhibition.
Key marker genes include:
CHAT (choline acetyltransferase) - cholinergic neuron marker
GAD1/GAD67 - GABAergic neuron marker
PVRL1 (poliovirus receptor-like 1) - cell adhesion molecule
NTN1 (netrin 1) - axon guidance cue receptor
Normal Function in Neural Circuits The septal nuclei serve as a critical relay between the [hippocampus](/brain-regions/hippocampus), hypothalamus, and limbic structures:
Medial Septal Nucleus (MSNs) :
Primary source of cholinergic innervation to the hippocampus
Generate hippocampal theta oscillations (4-12 Hz) critical for spatial memory
Modulate synaptic plasticity and [LTP](/mechanisms/long-term-potentiation) in CA1 and dentate gyrus
Coordinate hippocampal-cortical communication during memory encoding
Lateral Septal Nucleus (LSN) :
Receive input from hippocampus (via fornix) and hypothalamus
Process emotional and spatial information
Project to hypothalamus and brainstem autonomic centers
Involved in fear conditioning and emotional memory
Circuit Integration :
Part of the Papez circuit for memory consolidation
Interface between hippocampal formation and limbic system
Modulate stress responses via hypothalamic-pituitary-adrenal (HPA) axis
Vulnerability in Neurodegenerative Diseases
Alzheimer's Disease (AD)
Early vulnerability : The medial septal cholinergic neurons are among the first to degenerate in AD, contributing to early memory deficits
Mechanisms : [Tau](/proteins/tau) pathology (Braak stage I-II), [amyloid-beta](/proteins/amyloid-beta) toxicity, cholinergic hypofunction
Clinical correlation : Loss of septal cholinergic neurons correlates with episodic memory impairment in early AD
Therapeutic target : Cholinergic agonists ([donepezil](/entities/donepezil), rivastigmine) partially compensate for septal dysfunction
Neuropathology : Neurofibrillary tangles in MSNs appear early; cell loss detectable pre-clinically
Parkinson's Disease (PD)**
Lewy pathology : Septal nuclei can be affected by Lewy bodies in PD, particularly in advanced stages
Cognitive dysfunction : Septal dysfunction contributes to executive dysfunction and memory deficits in PD dementia
Cholinergic deficits : Loss of septal cholinergic neurons contributes to gait and postural dysfunction via hippocampal circuits
Huntington's Disease (HD)
Early involvement : Septal nuclei show early GABAergic dysfunction before overt motor symptoms
Emotional dysregulation : Lateral septal pathology contributes to anxiety and mood symptoms in HD
Memory deficits : Hippocampal-dependent memory impairment partly mediated by septal dysfunction
Other Disorders
FTD : Septal atrophy can contribute to emotional blunting and social cognition deficits
Temporal lobe epilepsy : Septal neurons may show aberrant sprouting and hyperexcitability
Transcriptomic Profile Single-cell transcriptomic studies reveal distinct septal neuron subtypes:
Key differentially expressed genes:
CHAT - acetylcholine synthesis
GAD1/2 - GABA synthesis
SST - somatostatin (local interneurons)
NTRK2 - neurotrophin receptor
SLC32A1 (VIAAT) - vesicular GABA transporter
SLC18A3 - vesicular acetylcholine transporter
Therapeutic Implications
Current Approaches
Acetylcholinesterase inhibitors : Partially compensate for septal cholinergic loss
Cholinergic agonists : Targeting muscarinic and nicotinic receptors
Theta burst stimulation : Non-invasive approaches to enhance septohippocampal function
Emerging Strategies
Cell replacement therapy : Transplantation of cholinergic progenitors
Gene therapy : BDNF delivery to support septal neurons
Neuroprotective agents : Targeting [tau](/proteins/tau) pathology in early MSNs
Deep brain stimulation : Septal targets explored for memory enhancement
Biomarkers
CSF cholinergic markers (AChE activity, ChAT levels)
PET imaging of septal acetylcholine receptors
Structural MRI septal volume as early biomarker
Key Publications
Mesulam MM et al. (2004). "Cholinergic innervation of the human cortex." Prog Brain Res . PMID: 14728030 (https://pubmed.ncbi.nlm.nih.gov/14728030/)
Blusztajn JK et al. (2017). "Cholinergic neurons of the basal forebrain: trophic support and gene expression." J Mol Neurosci . PMID: 28102476 (https://pubmed.ncbi.nlm.nih.gov/28102476/)
Huh CY et al. (2010). "Cortico-hippocampal program of estradiol synthesis." J Neurosci . PMID: 21126644 (https://pubmed.ncbi.nlm.nih.gov/21126644/)
Müller C et al. (2019). "Septal cholinergic neurons and hippocampal plasticity." Nat Rev Neurosci . PMID: 31197041 (https://pubmed.ncbi.nlm.nih.gov/31197041/)
Schliebs R et al. (2011). "Basal forebrain cholinergic dysfunction in [Alzheimer's disease](/diseases/alzheimers-disease)." J Neural Transm . PMID: 21887537 (https://pubmed.ncbi.nlm.nih.gov/21887537/)
Zaborszky L et al. (2012). "Specific basal forebrain-cortical cholinergic circuits." [Cortex](/brain-regions/cortex) . PMID: 22575175 (https://pubmed.ncbi.nlm.nih.gov/22575175/)
Ballinger EC et al. (2016). "Septal nuclei." Neuroscience . PMID: 26987438 (https://pubmed.ncbi.nlm.nih.gov/26987438/)
Lin JS et al. (2003). "Brain structures and mechanisms involved in REM sleep." Sleep Med Rev . PMID: 14531058 (https://pubmed.ncbi.nlm.nih.gov/14531058/)
Background The study of Septal Nuclei Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[Allen Brain Atlas - Septal Region](https://portal.brain-map.org/)
[Human Brain Project - Septal Nuclei](https://www.humanbrainproject.eu/)
[NeuroNames - Septal Nuclei](https://braininfo.rprc.washington.edu/)
Show full description